AAT as a diagnostic tool

Clinica Chimica Acta

Volumn 352, Issue 1-2, 2005, Pages 1-13

  Lisowska Myjak, Barbara ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Acute phase protein; Alpha 1 antitrypsin deficiency; Alpha 1 antitrypsin quantifications; Protease antiprotease imbalance; Protein losing enteropathy; Vascular diseases

Indexed keywords

ALPHA 1 ANTITRYPSIN; BIOCHEMICAL MARKER; PLASMA PROTEIN;

AGE DISTRIBUTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; ANEURYSM; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; EMPHYSEMA; FECES ANALYSIS; GASTROINTESTINAL DISEASE; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNOASSAY; INFLAMMATION; KIDNEY DISEASE; LIVER DISEASE; LUNG DISEASE; PANNICULITIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; PROTEIN URINE LEVEL; PROTEIN VARIANT; REVIEW; SCREENING TEST; SEX DIFFERENCE; VASCULITIS;

ALPHA 1-ANTITRYPSIN; ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; KIDNEY DISEASES; LUNG DISEASES;

EID: 11844263886     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.03.012     Document Type: Review

References (80)

1. 1-antitrypsin deficiency. Scand. J. Clin. Lab. Invest. 15:1963;132-140
2. Luisetti M. Introduction: the history of the Alpha One International Registry (A.I.R.). Respir. Med. 94(Suppl. C):2000;S1-S2
3. Stockley R.A. Alpha-1-antitrypsin deficiency. what next? Thorax. 55:2000;614-618
4. 1-antitrypsin deficiency: a critical review and cost-effectiveness analysis. Chest. 117:2000;875-880
5. 1- Antitrypsin deficiency: a report from the 2nd meeting of the Alpha One International Registry, Rapallo (Genoa, Italy), 2001. Eur. Respir. J. 20(4):2002;1050-1056
6. 1-antitrypsin deficiency: incidence and detection program. Respir. Med. 94(Suppl. C):2000;S18-S21
7. 1- antitrypsin deficiency identified neonatally: their health, knowledge about and adaptation to the high risk condition. Acta Pædiatr. 86:1997;37-40
8. 1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest. 122:2002;1818-1829
9. Khan H., Salman K.A., Ahmed S. Alpha-1 antitrypsin deficiency in emphysema. J. Assoc. Physicians India. 50:2002;579-582
10. Miravitlles M. Alpha 1-antitrypsin deficiency: epidemiology and prevalence. Respir. Med. 94(Suppl. C):2000;S12-S15
11. Mullins C.D., Wang J., Stoller J.K. Major components of the direct medical costs of alpha1-antitrypsin deficiency. Chest. 124(3):2003;826-831
12. Montanelli A., Mainardi E., Pini L., Corda L., Grassi V. Alpha-1-antitrypsin deficiency and nephropathy. Nephron. 90:2002;114-116
13. Vila N., Millán M., Ferrer X., Riutort N., Escudero D. Levels of alpha1-antitrypsin in plasma and risk of spontaneous cervical artery dissections: a case-control study. Stroke. 34(9):2003;e168-e169
14. Luft F.C. Alpha-1-antitrypsin and its relevance to human disease. J. Mol. Med. 77:1999;359-360
15. 1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. J. Clin. Invest. 110:2002;1579-1583
16. 1-antitrypsin deficiency and inflammatory bowel disease. Mayo. Clin. Proc. 75:2000;450-455
17. Coakley R.J., Taggart C., O'Neill S., McElvaney N.G. Alpha1-antitrypsin deficiency: biological answers to clinical questions. Am. J. Med. Sci. 321(1):2001;33-41
18. 1-antitrypsin, and haptoglobin: a comparison of a large cohort to the world's literature. J. Clin. Lab. Anal. 14:2000;265-270
19. 1- antitrypsin, and haptoglobin: a practical, simple, and clinically relevant approach in a large cohort. J. Clin. Lab. Anal. 14:2000;284-292
20. 1- antitrypsin phenotypes. Chest. 100:1991;703-708
21. Engstrom G., Lind P., Hedblad B., Stavenow L., Janzon L., Lindgärde F. Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke. Stroke. 33:2002;2744-2749
22. Engstrom G., Janzon L., Berglund G., Lind P., Stavenow L., Hedblad B., et al. Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. Arterioscler. Thromb. Vasc. Biol. 22:2002;2054-2058
23. 1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J. Clin. Invest. 110:2002;1585-1590
24. Lee J.H., Brantly M. Molecular mechanisms of alpha-1-antitrypsin null alleles. Respir. Med. 94(Suppl. C):2000;S7-S11
25. 1-antitrypsin deficiency: The Copenhagen City Heart Study. Circulation. 107:2003;747-752
26. Layden T.J., Kulik L. Hepatic manifestations of pulmonary diseases. Clin. Liver Dis. 6:2002;969-979
27. Alpha-1 Antitrypsin Deficiency Task Force Standards for the diagnosis and management of individuals with Alpha-1 Antitrypsin Deficiency: executive summary. Respir. Care. 48:2003;1043-1047
28. Costa X., Jardi R., Rodriguez F., Miravitlles M., Cotrina M., Gonzalez C., et al. Simple method for alpha-1-antitrypsin deficiency screening by use of dried blood spot specimens. Eur. Respir. J. 15:2000;1111-1115
29. Wencker M., Marx A., Konietzko N., Schaefer B., Campbell E.J. Screeening for alpha1-Pi deficiency in patients with lung diseases. Eur. Respir. J. 20(2):2002;319-324
30. 1-antitrypsin deficiency - a model for conformational diseases. N. Engl. J. Med. 346:2002;45-53
31. Pierce J.A. Alpha 1-antitrypsin augmentation therapy. Chest. 112:1997;872-874
32. Lomas D.A. Loop-sheet polymerization: the mechanism of alpha1-antitrypsin deficiency. Respir. Med. 94(Suppl. C):2000;S3-S6
33. 1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. J. Clin. Invest. 110(11):2002;1579-1583
34. Fischer H.P., Ortiz-Pallardo M.E., Ko Y., Esch C., Zhou H. Chronic liver disease in heterozygous alpha 1-antitrypsin deficiency PiZ. J. Hepatol. 33:2000;883-892
35. Perlmutter D.H. The SEC receptor: a possible link between neonatal hepatitis in alpha1-antitrypsin deficiency and Alzheimer's disease. Pediatr. Res. 36(3):1994;271-277
36. Francavilla R., Castellanneta S.P., Hadzic N., Chambers S.M., Portmann B., Tung J., et al. Prognosis of alpha-1-antitrypsin deficiency-related liver disease in the era of paediatric liver transplantation. J. Hepatol. 32(6):2000;986-992
37. Melvin T., Kim Y., Michael A.F. Selective binding of IgG4 and other negatively charged plasma proteins in normal and diabetic human kidneys. Am. J. Pathol. 115:1984;443-446
38. Liew C.T. Alpha-1-antitrypsin in the renal tubular epithelium in patients with or without alpha-1-antitrypsin deficiency. Changgeng Yi Xue Za Zhi. 13:1990;1-9
39. Davis I.D., Burke B., Freese D., Sharp H.L., Kim Y. The pathologic spectrum of the nephropathy associated with alpha-1-antitrypsin deficiency. Hum. Pathol. 23:1992;57-62
40. Lhotta K. Beyond hepatorenal syndrome: glomerulonephritis in patients with liver disease. Semin. Nephrol. 22(4):2002;302-308
41. Lisowska-Myjak B., Pachecka J., Witak P., Radowicki S. Comparison of urinary excretion of albumin and alpha-1-antitrypsin in patients with arterial hypertension. Scand. J. Clin. Lab. Invest. 59:1999;93-98
42. 1-Antitrypsin deficiency alleles and blood pressure in an Australian population. Clin. Exp. Pharmacol. Physiol. 23:1996;600-601
43. Boomsma D.I., Orbeleke J.F., Martin N.G., Frants R.R., Clark P. Alpha-1-antitrypsin and blood pressure. Lancet. 337:1991;1547
44. Fiotti N., Giansante C., Ponte E., Delbello C., Calabrese S., Zacchi T., et al. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis. 145:1999;51-60
45. Pezzini A., Magoni M., Corda L., Pini L., Medicina D., Crispino M., et al. Alpha-1-antitrypsin deficiency-associated cervical artery dissection: report of three cases. Eur. Neurol. 47:2002;201-204
46. Gaglio P.J., Regenstein F., Slakey D., Cheng S., Takiff H., Rinker R., et al. Alpha-1-antitrypsin deficiency and splenic artery aneurysm rupture: an association? Am. J. Gastroenterol. 95:2000;1531-1534
47. Elzouki A.N.Y., Eriksson S. Abdominal aortic aneurysms and alpha1-antitrypsin deficiency. J. Intern. Med. 236:1994;587-591
48. Baker C.J., Fiore A., Connolly E.S., Baker K.Z., Solomon R.A. Serum elastase and alpha-1-antitrypsin levels in patients with ruptured and unruptured cerebral aneurysms. Neurosurgery. 37:1995;56-62
49. St. Jean P., Hart B., Webster M., Steed D., Adamson J., Powell J., et al. Alpha-1-antitrypsin deficiency in aneurysmal disease. Hum. Hered. 46:1996;92-97
50. Mazodier P., Elzouki A.N.Y., Segelmark M., Eriksson S. Systemic necrotizing vasculitides in severe alpha 1-antitrypsin deficiency. QJM. 89:1996;599-611
51. Savige J.A., Chang L., Cook L., Burdon J., Daskalakis M., Doery J. Alpha-1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin. Exp. Immunol. 100:1995;194-197
52. Barnett V.T., Sekosan M., Khurshid A. Wegener's granulomatosis and alpha-1-antitrypsin deficiency emphysema: proteinase-related diseases. Chest. 116:1999;253-255
53. Parr D.G., Stewart D.G., Hero I., Stockley R.A. Panniculitis secondary to extravasation of clarithromycin in a patient with alpha-1-antitrypsin deficiency (phenotype PiZ). Br. J. Dermatol. 149:2003;410-413
54. Mc Bean J., Sable A., Maude J., Robinson-Bostom L. Alpha-1antitrypsin deficiency panniculitis. Cutis. 71:2003;205-209
55. Chowdhury M.M., Williams E.J., Morris J.S., Ferguson B.J., McGregor A.D., Hedges A.R., et al. Severe panniculitis caused by homozygous ZZ alpha1-antitrypsin deficiency treated successfully with human purified enzyme (Prolastin). Br. J. Dermatol. 147:2002;1258-1261
56. Elzouki A.N., Eriksson S., Lofberg R., Nassberger L., Wieslander J., Lindgren S. The prevalence and clinical significance of alpha-1-antitrypsin deficiency (PiZ) and ANCA specificities (proteinase 3, BPI) in patients with ulcerative colitis. Inflamm. Bowel Dis. 5:1999;246-252
57. 1-antitrypsin deficiency may be a risk factor for duodenal ulcer in patients with Helicobacter pylori infection. Scand. J. Gastroenterol. 35:2000;32-35
58. Folwaczny C., Urban S., Shroder M., Hofmann B., Noehl N., Konig A., et al. Alpha1-antitrypsin alleles and phenotypes in patients with inflammatory bowel disease. Scand. J. Gastroenterol. 33:1998;78-81
59. Borgstrom A., Ohlsson K. Do trypsin 2-alpha-1-antitrypsin complexes occur naturally in the circulation? Gut. 43(6):1998;861
60. Andersen M.J., Hedstrom J., Tikanoja T., Leijala M., Rautiainen P., Stenman U.H. Elevated levels of trysinogen-2 and trypsin-2-alpha1-antitrypsin in sera of infants and children after cardiac surgery. Scand. J. Clin. Lab. Invest. 62:2002;89-96
61. 1-antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomas. Int. J. Cancer. 66:1996;326-331
62. Sharpstone D., Rowbottom A., Nelson M., Gazzard B. Faecal alpha-1-antitrypsin as a marker of gastrointestinal disease in HIV antibody positive individuals. Gut. 38:1996;206-210
63. Lisowska-Myjak B., Pachecka J., Sokrates O., Brzozowska-Binda A., Torbicka E. Fecal alpha-1-antitrypsin excretion in children with diarrhea. Scand. J. Gastroenterol. 33:1998;255-259
64. Matoth I., Granot E., Gorenstein A., Abu-Dalu K., Goitein K. Gastrointestinal protein loss in children recovering from burns. J. Pediatr. Surg. 26:1991;1175-1178
65. van der Sluys Veer A., Biemond I., Verspaget H.W., Lamers C.B. Faecal parameters in the assessment of activity in inflammatory bowel disease. Scand J. Gastroenterol. Suppl. 230:1999;106-110
66. Choudhary S., Gibson P.R., Deacon M.C., Young G.P. Measurement of faecal alpha 1-antitrypsin: methodologies and clinical application. J. Gastroenterol. Hepatol. 11:1996;311-318
67. 1-antitrypsin clearance and fecal concentration as early indicator of postoperative asymptomatic recurrence in Crohn's disease. Dig. Dis. Sci. 36:1991;347-352
68. Weizman Z., Binsztok M., Fraser D., Deckelbaum R.J., Granot E. Intestinal protein loss in acute and persistent diarrhea of early childhood. J. Clin. Gastroenterol. 34:2002;427-429
69. Fontana M., Zuin G., Galli L., Paccagnini S., Villa M., Loguercio L. Fecal alpha-1-antitrypsin excretion in acute diarrhea: relationship with causative pathogens. Helv. Paediatr. Acta. 43:1988;211-218
70. Thorne S.A., Hooper J., Kemp M., Somerville J. Gastro-intestinal protein loss in late survivors of Fontan surgery and other congenital heart disease. Eur. Heart J. 19:1998;514-520
71. 1-Antitrypsin clearance as an aid in the management of patients with celiac disease. Am. J. Gastroenterol. 86:1991;986-991
72. Saarinen K.M., Sarnesto A., Savilahti E. Markers of inflammation in the feces of infants with cow's milk allergy. Pediatr. Allergy Immunol. 13:2002;188-194
73. Magazzu G., Scoglio R. Gastrointestinal manifestation of cow's milk allergy. Ann. Allergy, Astma, & Immun. 89(Suppl. 1):2002;65-68
74. Majamaa H., Miettinen A., Laine S., Isolauri E. Intestinal inflammation in children with atopic eczema: faecal eosinophil cationic protein and tumour necrosis factor-alpha as non-invasive indicators of food allergy. Clin. Exp. Allergy. 26:1996;181-187
75. McMillan D.E. Increased levels of acute phase serum proteins in diabetes. Metabolism. 38:1989;1042
76. 2-macroglobulin in human serum: application to insulin-dependent diabetes mellitus. Clin. Immunol. Immunopathol. 89:1998;247-259
77. Engstrom G., Stavenov l., Hedblad Bo., Lidn P., Eriksson K.F., Janzon L., et al. Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes. 52:2003;442-447
78. Solerte S.B., Fioravanti M. Hemodynamic alterations in long-term insulin-dependent diabetic patients with overt nephropathy: role of blood hyperviscosity and plasma protein changes. Clin. Nephrol. 28:1987;138-143
79. Lisowska-Myjak B., Sygitowicz G., Wolf B., Pachecka J. Serum alpha-1-antitrypsin concentration during normal and diabetic pregnancy. Eur. J. Obstet. Gynecol. 99:2001;53-56
80. Ritz S., Mehlan G., Martz W. Postmortem diagnosis of diabetic metabolic derangement: elevated alpha1-antitrypsin and haptoglobin glycosylation levels as an index of antemortem hyperglycemisa. J. Forensic Sci. 41(1):1996;94-100